🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an Open, Single Arm, Exploratory and Phase II Clinical Trial of Anl...
Status
Recruiting
Location
Jiangxi Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05252078
Treatments Being Tested
This is a single-arm, open-label and exploratory clinical study of Anlotini...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2019-06-10
Trial ID
NCT04052152
Treatments Being Tested
This is An Open, Single Arm, Multicenter, Exploratory Phase II study, to ev...
Status
Unknown
Location
Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University)
Start Date
2022-01-06
Trial ID
NCT05111366
Treatments Being Tested
Anlotinib hydrochloride is a multi-targeted receptor tyrosine kinase inhibi...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2019-10-31
Trial ID
NCT04073537
Treatments Being Tested
TQB2450 is a humanized monoclonal antibody targeting programmed death ligan...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-06-24
Trial ID
NCT03996408
This is a randomized, controlled, open-label, multicenter study to evaluate...
Status
Unknown
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2020-05-20
Trial ID
NCT04385550
Treatments Being Tested
This study aims to observe and explore the efficacy and safety of Anlotinib...
Status
Unknown
Location
YansongLin
Start Date
2023-11-11
Trial ID
NCT06062563
Treatments Being Tested
To assess the efficacy and safety of TQB2450 in combination with anlotinib ...
Status
Unknown
Location
Cancer Hospital Affiliated to Shandong First Medical University
Start Date
2023-05-30
Trial ID
NCT05942508
Treatments Being Tested
A randomized, double-blind, controlled, multicenter phase III study of TQB2...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-01
Trial ID
NCT04234607
Treatments Being Tested
Evaluate the efficacy and safety of Anlotinib plus Icotinib as the first-li...
Status
Completed
Location
Hebei Provincial People's Hospital
Start Date
2018-12-01
Trial ID
NCT03736837
Treatments Being Tested